Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients
NCT05129462
·
clinicaltrials.gov ↗
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Sponsor
Hunan Province Tumor Hospital